Literature DB >> 11799031

Analysis of adherence to peak flow monitoring when recording of data is electronic.

Helen K Reddel1, Brett G Toelle, Guy B Marks, Sandra I Ware, Christine R Jenkins, Ann J Woolcock.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11799031      PMCID： PMC64515          DOI： 10.1136/bmj.324.7330.146

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Optimal asthma control, starting with high doses of inhaled budesonide.

Authors:  H K Reddel; C R Jenkins; G B Marks; S I Ware; W Xuan; C M Salome; C A Badcock; A J Woolcock
Journal:  Eur Respir J       Date:  2000-08       Impact factor: 16.671

2.  Compliance with and accuracy of daily self-assessment of peak expiratory flows (PEF) in asthmatic subjects over a three month period.

Authors:  P Verschelden; A Cartier; J L'Archevêque; C Trudeau; J L Malo
Journal:  Eur Respir J       Date:  1996-05       Impact factor: 16.671

3.  Pitfalls in processing home electronic spirometric data in asthma.

Authors:  H K Reddel; S I Ware; C M Salome; C R Jenkins; A J Woolcock
Journal:  Eur Respir J       Date:  1998-10       Impact factor: 16.671

4.  Do asthmatic patients correctly record home spirometry measurements?

Authors:  P J Chowienczyk; D H Parkin; C P Lawson; G M Cochrane
Journal:  BMJ       Date:  1994-12-17
  4 in total
  13 in total

1.  Compliance and reliability of electronic PEF monitoring in adolescents with asthma.

Authors:  V van der Meer; E R V M Rikkers-Mutsaerts; P J Sterk; H A Thiadens; W J J Assendelft; J K Sont
Journal:  Thorax       Date:  2006-05       Impact factor: 9.139

2.  Measuring peak flow enhances adherence to monitoring in asthma.

Authors:  Cassandra A Slader; Elena G Belousova; Helen K Reddel
Journal:  Thorax       Date:  2007-08       Impact factor: 9.139

Review 3.  Asthma outcomes: symptoms.

Authors:  Jerry A Krishnan; Robert F Lemanske; Glorisa J Canino; Kurtis S Elward; Meyer Kattan; Elizabeth C Matsui; Herman Mitchell; E Rand Sutherland; Michael Minnicozzi
Journal:  J Allergy Clin Immunol       Date:  2012-03       Impact factor: 10.793

Review 4.  Targeting patients with asthma for omalizumab therapy: choosing the right patient to get the best value for money.

Authors:  Abir Al Said; Breda Cushen; Richard W Costello
Journal:  Ther Adv Chronic Dis       Date:  2017-02-01       Impact factor: 5.091

5.  Assessing differences in inhaled corticosteroid response by self-reported race-ethnicity and genetic ancestry among asthmatic subjects.

Authors:  Karen E Wells; Sonia Cajigal; Edward L Peterson; Brian K Ahmedani; Rajesh Kumar; David E Lanfear; Esteban G Burchard; L Keoki Williams
Journal:  J Allergy Clin Immunol       Date:  2016-03-22       Impact factor: 10.793

6.  A cluster-randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma.

Authors:  L Keoki Williams; Edward L Peterson; Karen Wells; Janis Campbell; Mingqun Wang; Vimal K Chowdhry; Matthew Walsh; Robert Enberg; David E Lanfear; Manel Pladevall
Journal:  J Allergy Clin Immunol       Date:  2010-05-31       Impact factor: 10.793

Review 7.  Measures of asthma control.

Authors:  Christian Bime; Jessica Nguyen; Robert A Wise
Journal:  Curr Opin Pulm Med       Date:  2012-01       Impact factor: 3.155

Review 8.  The need for standardisation of peak flow charts.

Authors:  H K Reddel; S D Vincent; J Civitico
Journal:  Thorax       Date:  2005-02       Impact factor: 9.139

9.  Adherence to peak flow monitoring. Information provided by meters should be part of self management plan.

Authors:  Ann-Louise Caress; Karen Luker; Kinta Beaver; Ashley Woodcock
Journal:  BMJ       Date:  2002-05-11

10.  Clinical and cost effectiveness of mobile phone supported self monitoring of asthma: multicentre randomised controlled trial.

Authors:  Dermot Ryan; David Price; Stan D Musgrave; Shweta Malhotra; Amanda J Lee; Dolapo Ayansina; Aziz Sheikh; Lionel Tarassenko; Claudia Pagliari; Hilary Pinnock
Journal:  BMJ       Date:  2012-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.